Michael Leviten
No más puestos en curso
Perfil
Michael Leviten worked as a Director-Molecular Biology at Bayhill Therapeutics, Inc. from 2005 to 2013.
He also worked as a Senior Scientist at Deltagen, Inc. Dr. Leviten received his undergraduate degree from Harvard University and his doctorate degree from the University of California San Diego.
Antiguos cargos conocidos de Michael Leviten.
| Empresas | Cargo | Fin |
|---|---|---|
Bayhill Therapeutics, Inc.
 Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | 26/12/2013 |
| DELTAGEN INC. | Director Técnico/Científico/I+D | - |
Formación de Michael Leviten.
| Harvard University | Undergraduate Degree |
| University of California San Diego | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| DELTAGEN INC. | Commercial Services |
| Empresas privadas | 1 |
|---|---|
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Michael Leviten
